Skip to main content
Mayinglong Pharmaceutical Group Co.,Ltd logo

Mayinglong Pharmaceutical Group Co.,Ltd — Investor Relations & Filings

Ticker · 600993 ISIN · CNE000001HN2 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 931 across all filing types
Latest filing 2010-05-22 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 600993

About Mayinglong Pharmaceutical Group Co.,Ltd

https://www.mayinglong.cn/

Mayinglong Pharmaceutical Group Co.,Ltd. is a long-established enterprise specializing in the research, development, and production of Traditional Chinese Medicine (TCM). Founded in 1582, the company is widely recognized for its expertise in proctology, maintaining a dominant market position with its signature hemorrhoid ointments and suppositories. Its product portfolio also includes ophthalmic preparations, dermatological treatments, and gastrointestinal medicines. The company integrates traditional medicinal formulas with modern manufacturing technologies to provide healthcare solutions. Beyond pharmaceuticals, Mayinglong has expanded into healthcare services, including specialized hospitals and personal care products, focusing on the integration of clinical treatment and health management.

Recent filings

Filing Released Lang Actions
第七届监事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolution from the first meeting of the seventh supervisory board of the company, including the election of the chairman of the supervisory board. It is a formal announcement about board/management changes, specifically related to the supervisory board leadership. There is no financial data, no report publication, no voting results, or other types of filings. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is a direct announcement, not a report or certification.
2010-05-22 Chinese
2009年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement from the 2009 Annual General Meeting (AGM) of the company 马应龙药业集团股份有限公司. It details the meeting date, attendance, proposals voted on, voting results, and election of board members and supervisors. It also includes legal opinions and biographies of directors and supervisors. The content is focused on the outcomes and decisions made at the AGM rather than the full annual report or financial statements themselves. The document length is 4278 characters, which is relatively short and consistent with an announcement of AGM resolutions rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2010-05-22 Chinese
2009年年度股东大会会议资料
AGM Information Classification · 100% confidence The document is titled as materials for the 2009 Annual General Meeting (AGM) of 马应龙药业集团股份有限公司. It includes detailed agenda items typical for an AGM, such as the review and approval of the 2009 annual report and summary, financial statements, profit distribution plan, board and supervisory committee reports, appointment of auditors, amendments to company articles, and board elections. The content is comprehensive and intended for shareholder review and voting during the AGM. It is not a standalone annual report (10-K) or a simple announcement but the actual meeting materials and agenda. Therefore, the document fits the category of AGM Information (AGM-R). The document length (15,000 characters) and detailed content confirm it is the meeting materials, not just an announcement or summary.
2010-05-14 Chinese
第六届董事会第十七次会议决议公告暨召开公司2009年年度股东大会的通知
AGM Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 17th meeting of the 6th Board of Directors of Mayinglong Pharmaceutical Group Co., Ltd., including the notice of the 2009 Annual General Meeting (AGM). It includes agenda items for the AGM such as approval of the 2009 Annual Report, financial statements, profit distribution plan, board work report, independent directors' report, supervisory board report, appointment of auditors, amendments to the Articles of Association, and board election proposals. It also contains detailed information about the board candidates, independent directors' declarations, and procedures for attending the AGM. The document is not the annual report itself but a notice and resolutions related to the AGM and board matters. Therefore, it fits best under AGM Information (AGM-R) as it is the meeting notice and related materials for the Annual General Meeting.
2010-04-24 Chinese
第六届监事会第十三次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the supervisory board of Mayinglong Pharmaceutical Group Co., Ltd. It details the approval of the company's 2010 first quarter report, the supervisory board's work report, and the proposal for the supervisory board's re-election. The document is short (1034 characters) and primarily serves as an announcement of meeting resolutions rather than containing the full quarterly report or detailed financial data. It does not contain the actual financial statements or substantive financial analysis but rather the approval and procedural details of the report and board matters. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a formal announcement of supervisory board decisions and report approvals without the full report content itself.
2010-04-24 Chinese
关于为子公司提供贷款担保额度的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by the board of directors of a company regarding the approval of loan guarantee limits for its subsidiaries. It details the amounts, the subsidiaries involved, their financial status, and the board's opinion on the guarantees. There is no financial report, audit report, or detailed financial statements included. The document is a formal announcement of a corporate action related to financing support (loan guarantees) for subsidiaries. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is best classified under Capital/Financing Update (CAP) as it concerns financing activities and guarantees provided by the company.
2010-04-24 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.